University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Correction to : Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT) (Radiation Oncology, (2021), 16, 1, (163), 10.1186/s13014-021-01888-1)

Simple item page
dc.contributor.authorHanna, Catherine R.
dc.contributor.authorO’Cathail, Sean M.
dc.contributor.authorGraham, Janet S.
dc.contributor.authorSaunders, Mark
dc.contributor.authorSamuel, Leslie
dc.contributor.authorHarrison, Mark
dc.contributor.authorDevlin, Lynsey
dc.contributor.authorEdwards, Joanne
dc.contributor.authorGaya, Daniel R.
dc.contributor.authorKelly, Caroline A.
dc.contributor.authorLewsley, Liz Anne
dc.contributor.authorMaka, Noori
dc.contributor.authorMorrison, Paula
dc.contributor.authorDinnett, Louise
dc.contributor.authorDillon, Susan
dc.contributor.authorGourlay, Jacqueline
dc.contributor.authorPlatt, Jonathan J.
dc.contributor.authorThomson, Fiona
dc.contributor.authorAdams, Richard A.
dc.contributor.authorRoxburgh, Campbell S.D.
dc.contributor.institutionUniversity of Aberdeen.Medicine, Medical Sciences & Nutritionen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Evaluationen
dc.date.accessioned2022-01-14T20:32:01Z
dc.date.available2022-01-14T20:32:01Z
dc.date.issued2021-12
dc.descriptionFunding Information: After publication of this article, the authors reported that the Funding information section was incomplete. The following should have been added: “This work was supported by CRUK (Grant Number C61974/A2429).”en
dc.description.statusPeer revieweden
dc.format.extent1
dc.format.extent579329
dc.identifier211735453
dc.identifier8f68f15f-a96e-48e8-b463-db33666e2cb8
dc.identifier85120734988
dc.identifier34857017
dc.identifier.citationHanna, C R, O’Cathail, S M, Graham, J S, Saunders, M, Samuel, L, Harrison, M, Devlin, L, Edwards, J, Gaya, D R, Kelly, C A, Lewsley, L A, Maka, N, Morrison, P, Dinnett, L, Dillon, S, Gourlay, J, Platt, J J, Thomson, F, Adams, R A & Roxburgh, C S D 2021, 'Correction to : Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT) (Radiation Oncology, (2021), 16, 1, (163), 10.1186/s13014-021-01888-1)', Radiation Oncology, vol. 16, 230. https://doi.org/10.1186/s13014-021-01941-zen
dc.identifier.doi10.1186/s13014-021-01941-z
dc.identifier.issn1748-717X
dc.identifier.otherORCID: /0000-0002-8402-8670/work/106597566
dc.identifier.urihttps://hdl.handle.net/2164/17879
dc.identifier.urlhttps://www.scopus.com/pages/publications/85120734988en
dc.language.isoeng
dc.relation.ispartofRadiation Oncologyen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectR Medicine (General)en
dc.subjectOncologyen
dc.subjectRadiology Nuclear Medicine and imagingen
dc.subjectCancer Research UKen
dc.subjectC61974/A2429en
dc.subject.lccR1en
dc.titleCorrection to : Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT) (Radiation Oncology, (2021), 16, 1, (163), 10.1186/s13014-021-01888-1)en
dc.typeJournal itemen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Hanna_et_al_correction_durval_Radiation_oncology_vor.pdf
Size:
565.75 KB
Format:
Adobe Portable Document Format
Download

Collections

All research

The Sir Duncan Rice Library

University of Aberdeen

Bedford Road

Aberdeen

AB24 3AA


Tel: +44 (0)1224 273330

Email: library@abdn.ac.uk

Share and keep up to date


FacebookTwitterWordpress